Retraction
Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct down-regulation of MCAM in triple-negative breast cancer cells
Paper Information
Record ID:
49728
Author(s):
Journal:
Publication Date:
February 05, 2020
Retraction Date:
November 20, 2023
(2.0 year years ago)
Subjects:
Institutions:
- Department of Medical Oncology, Shantou University Medical College Cancer Hospital, Shantou, China
- Changjiang Scholar’s Laboratory, Shantou University Medical College (SUMC), Shantou, China
- Department of Thyroid and Breast Surgery, the First Affiliated Hospital of Shantou University Medical College, Shantou, China
- Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- Department of Thyroid Surgery, Shantou Central Hospital, Shantou, China
- Department of Pathology, Cancer Hospital of SUMC, Shantou, China
- he Cancer Center and the Department of Breast and Thyroid Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China
- Fujian Anti-Cancer Center, Fujian, China
Countries:
Article Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (54)
54
Total Citations10
Post-Retraction(18.5%)
44
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
6
Within 1 year
0
After 2+ years
467
Days since retraction (latest)
Melanoma Cell Adhesion Molecule Plays a Pivotal Role in Proliferation, Migration, Tumor Immune Microenvironment, and Immunotherapy in Colorectal Cancer
Jingkai Zhou, Jing Liu, Yali Yu et al. (12 authors)
Cancer Medicine
Open Access
Published: Mar 2025
467 days after retraction
CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway
Hao Qu, Fang Yan, Feng Zhang et al. (7 authors)
Frontiers in Pharmacology
Open Access
Published: Jan 2025
420 days after retraction
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski et al. (6 authors)
Cancers
Open Access
Published: Jan 2025
2 citations
2 citations
419 days after retraction
Enhanced antitumor immunity in breast cancer: Synergistic effects of ADAM10/ADAM17 inhibition, metabolic modulation, and camptothecin-loaded selenium nanoparticles
Mahshad Entezam, Nader Bagheri, Amin Soltani et al. (7 authors)
International Journal of Pharmaceutics
Published: Dec 2024
377 days after retraction
The molecular features of lung cancer stem cells (LCSCs) in dedifferentiation process-driven epigenetic alterations
Valentina Masciale, Federico Banchelli, Giulia Grisendi et al. (14 authors)
Journal of Biological Chemistry
Open Access
Published: Nov 2024
2 citations
2 citations
347 days after retraction
Reactive oxygen species induced by SARS-CoV-2 infection can induce EMT in solid tumors: potential role of COVID-19 in chemo-resistance and metastasis
Melina Moulaeian, Saeid Ferdousmakan, Sara Banihashemi et al. (6 authors)
Heliyon
Open Access
Published: Nov 2024
1 citation
1 citation
347 days after retraction
Prognostic and predictive impact of NOTCH1 in early breast cancer
Julia Engel, Vanessa Wieder, Marcus Bauer et al. (19 authors)
Breast Cancer Research and Treatment
Open Access
Published: Aug 2024
271 days after retraction
A molecular approach to triple-negative breast cancer: targeting the Notch signaling pathway
Isabele Pardo, Pedro Brecheret Fagundes, Roberta Beatriz Santos Oliveira et al. (4 authors)
Einstein (São Paulo)
Open Access
Published: Jan 2024
3 citations
3 citations
42 days after retraction
Ectopic expression of tumor suppressive miR-181c-5p downregulates oncogenic Notch signaling in MDA-MB-231 cells
Mohd Shuaib, Shashank Kumar
Pathology - Research and Practice
Published: Dec 2023
2 citations
2 citations
16 days after retraction
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
Tatiana J. Carneiro, Ana L. M. Batista de Carvalho, Martin Vojtek et al. (7 authors)
Cancer Cell International
Open Access
Published: Dec 2023
11 citations
11 citations
16 days after retraction
Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells
Yuzhu Qi, Meifang Li, Shaozhong Li et al. (9 authors)
Cell Death Discovery
Open Access
Published: Jun 2023
10 citations
10 citations
143 days before retraction
CD146 as a prognostic marker in breast cancer: A meta-analysis
Akshita Sharma, Indumathi Somasundaram, Marcel Blot Chabaud
Journal of Cancer Research and Therapeutics
Open Access
Published: Apr 2023
2 citations
2 citations
227 days before retraction
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu et al. (9 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Mar 2023
120 citations
120 citations
254 days before retraction
CD146‐targeted nuclear medicine imaging in cancer: State of the art
Qi Yang, Wenpeng Huang, Jessica C. Hsu et al. (8 authors)
View
Open Access
Published: Mar 2023
8 citations
8 citations
264 days before retraction
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain et al. (8 authors)
Journal of Advanced Research
Open Access
Published: Feb 2023
68 citations
68 citations
279 days before retraction
Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma
Zixuan Gao, Zhansheng Zhang, Qin Jia et al. (10 authors)
Phytomedicine
Published: Feb 2023
11 citations
11 citations
282 days before retraction
The Role of RNA Epitranscriptomics and the RNA Fat Mass and Obesity-Associated Demethylase in Triple Negative Breast Cancer
Emilija Sagaityte, Richard S. Dowd, Kendall Lane et al. (5 authors)
Advances in Breast Cancer Research
Open Access
Published: Jan 2023
323 days before retraction
DYRK2 downregulation in colorectal cancer leads to epithelial–mesenchymal transition induction and chemoresistance
Chunrong Wu, Guiyin Sun, Fan Wang et al. (12 authors)
Scientific Reports
Open Access
Published: Dec 2022
3 citations
3 citations
327 days before retraction
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer
Run-Chang Wang, Dongyang Gao, Chaohu Chen et al. (10 authors)
Clinical & Translational Oncology
Published: Dec 2022
7 citations
7 citations
342 days before retraction
ZEB1-activated Notch1 promotes circulating tumor cell migration and invasion in lung squamous cell carcinoma
Yong Gao, Xinyuan Cheng, Mingfeng Han
Clinical & Translational Oncology
Published: Nov 2022
4 citations
4 citations
362 days before retraction
Hsa_circ_0097271 Knockdown Attenuates Osteosarcoma Progression via Regulating miR-640/MCAM Pathway
Peng Sun, Xuan Yang
Disease Markers
Open Access
Published: Oct 2022
2 citations
2 citations
390 days before retraction
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
Xirui Duan, Maochao Luo, Jian Li et al. (5 authors)
Frontiers in Oncology
Open Access
Published: Oct 2022
16 citations
16 citations
402 days before retraction
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei et al. (14 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Oct 2022
111 citations
111 citations
413 days before retraction
miR-30c plays diagnostic and prognostic roles and mediates epithelial–mesenchymal transition (EMT) and proliferation of gliomas by affecting Notch1
Mengkao Li, Wenzhi Liu, Jian Li et al. (5 authors)
Scientific Reports
Open Access
Published: Sep 2022
1 citation
1 citation
416 days before retraction
CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells
Yuanke Liang, Xiaoling Zhou, Qin Xie et al. (11 authors)
Cancer Letters
Open Access
Published: Aug 2022
25 citations
25 citations
471 days before retraction
Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance
Zhimin Xu, Yingxin Zhang, Huanyan Dai et al. (4 authors)
Molecules
Open Access
Published: Jul 2022
44 citations
44 citations
483 days before retraction
CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling
Yuanke Liang, Daniëlle C. Voshart, Judith T.M.L. Paridaen et al. (12 authors)
Cellular and Molecular Life Sciences
Open Access
Published: Jul 2022
25 citations
25 citations
503 days before retraction
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties
Xiang Li, Yuying Wang, Yuanyuan Zhang et al. (4 authors)
Breast Cancer
Published: May 2022
2 citations
2 citations
557 days before retraction
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
Bernadette Xin Jie Tune, Maw Shin Sim, Chit Laa Poh et al. (15 authors)
Journal of Oncology
Open Access
Published: May 2022
37 citations
37 citations
560 days before retraction
Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway
Zhi Li, Haiyan Yang, Xiaolan Zhang et al. (10 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: May 2022
34 citations
34 citations
562 days before retraction
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
Ali Zarrabi, Anupam Bishayee, Sepideh Mirzaei et al. (13 authors)
Current Molecular Pharmacology
Published: Apr 2022
17 citations
17 citations
581 days before retraction
Epithelial–mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCC
Julia Lima de Oliveira, Thaís Moré Milan, Rayana Longo Bighetti‐Trevisan et al. (6 authors)
Oral Diseases
Published: Apr 2022
17 citations
17 citations
588 days before retraction
H3K27me3 conditions chemotolerance in triple-negative breast cancer
Justine Marsolier, Pacôme Prompsy, Adeline Durand et al. (20 authors)
Nature Genetics
Open Access
Published: Apr 2022
88 citations
88 citations
598 days before retraction
Neutrophil Extracellular Traps in Cancer Therapy Resistance
Muhammad H. Shahzad, Lixuan Feng, Xin Su et al. (8 authors)
Cancers
Open Access
Published: Mar 2022
50 citations
50 citations
623 days before retraction
Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins
Mengli Zhang, Mei Meng, Yuxi Liu et al. (11 authors)
Breast Cancer Research
Open Access
Published: Dec 2021
25 citations
25 citations
702 days before retraction
Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression
Sumit Siddharth, Sheetal Parida, Nethaji Muniraj et al. (10 authors)
eLife
Open Access
Published: Dec 2021
11 citations
11 citations
710 days before retraction
Identification of hub genes associated with EMT-induced chemoresistance in breast cancer using integrated bioinformatics analysis
Bhavjot Kaur, Yahya Mukhlis, Jagadish Natesh et al. (5 authors)
Gene
Published: Oct 2021
15 citations
15 citations
767 days before retraction
MiR-30c Plays Diagnostic and Prognostic Roles and Mediates Epithelial–mesenchymal Transition (EMT) and Proliferation of Glioma by Affecting Notch1
Mengkao Li, Wenzhi Liu, Jin Xu
Research Square (Research Square)
Open Access
Published: Aug 2021
1 citation
1 citation
822 days before retraction
Insights of Cisplatin Resistance in Cervical Cancer: A Decision Making for Cellular Survival
Elizabeth Mahapatra, Salini Das, Souvick Biswas et al. (7 authors)
IntechOpen eBooks
Open Access
Published: Aug 2021
6 citations
6 citations
823 days before retraction
Long Non-Coding RNA SNHG6 Supports Glioma Progression Through Upregulation of Notch1, Sox2, and EMT
Jing Nie, Yao Feng, He Wang et al. (5 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Aug 2021
10 citations
10 citations
829 days before retraction
The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential
Xiang Meng, Qiuyue Lou, Wenying Yang et al. (8 authors)
Cancer Communications
Open Access
Published: Jul 2021
96 citations
96 citations
853 days before retraction
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets
Sepideh Mirzaei, Asal Jalal Abadi, Mohammad Gholami et al. (12 authors)
European Journal of Pharmacology
Published: Jul 2021
36 citations
36 citations
860 days before retraction
Natural bioactive compounds from marine fungi (2017–2020)
Huan‐Nan Wang, Shanshan Sun, Mengzhen Liu et al. (7 authors)
Journal of Asian Natural Products Research
Published: Jul 2021
28 citations
28 citations
861 days before retraction
The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer
Kun Gao, Wenqun Xing, Xianben Liu et al. (7 authors)
Translational Cancer Research
Open Access
Published: Jun 2021
8 citations
8 citations
879 days before retraction
Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors
Kegong Chen, Long Bai, Lin Ji et al. (5 authors)
Medicine
Open Access
Published: Jun 2021
6 citations
6 citations
886 days before retraction
High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer Cells
Liang Dong, Chung‐Ying Huang, Eric Johnson et al. (11 authors)
Analytical Chemistry
Open Access
Published: Feb 2021
19 citations
19 citations
1006 days before retraction
Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective
Abdellah Akil, Ana K. Gutiérrez-García, Rachael Guenter et al. (7 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Feb 2021
148 citations
148 citations
1007 days before retraction
ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models
Cuicui Li, Lei Kang, Kevin Fan et al. (13 authors)
Bioconjugate Chemistry
Open Access
Published: Jan 2021
23 citations
23 citations
1033 days before retraction
H3K27me3 is a determinant of chemotolerance in triple-negative breast cancer
Justine Marsolier, Pacôme Prompsy, Adeline Durand et al. (19 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2021
4 citations
4 citations
1050 days before retraction
Notch signaling in female cancers: a multifaceted node to overcome drug resistance
Maria Valeria Giuli, Angelica Mancusi, Eugenia Giuliani et al. (5 authors)
Cancer Drug Resistance
Open Access
Published: Jan 2021
18 citations
18 citations
1053 days before retraction
Quick Stats
Total Citations:
54
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025